Greenwood Capital Associates’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.7M | Sell |
65,749
-18,868
| -22% | -$1.81M | 0.63% | 51 |
|
|
2025
Q4 | $8.13M | Sell |
84,617
-1,680
| -2% | -$163K | 0.88% | 32 |
|
|
2025
Q3 | $8.22M | Buy |
86,297
+2,375
| +3% | +$218K | 0.95% | 26 |
|
|
2025
Q2 | $7.32M | Sell |
83,922
-27,723
| -25% | -$2.35M | 0.91% | 28 |
|
|
2025
Q1 | $10M | Buy |
111,645
+15,281
| +16% | +$1.37M | 1.35% | 12 |
|
|
2024
Q4 | $7.7M | Sell |
96,364
-101
| -0.1% | -$8.74K | 1% | 28 |
|
|
2024
Q3 | $8.68M | Sell |
96,465
-1,473
| -2% | -$124K | 1.13% | 22 |
|
|
2024
Q2 | $7.71M | Buy |
97,938
+27,844
| +40% | +$2.28M | 1.01% | 25 |
|
|
2024
Q1 | $6.11M | Buy |
70,094
+52,648
| +302% | +$4.49M | 0.81% | 46 |
|
|
2023
Q4 | $1.44M | Buy |
17,446
+800
| +5% | +$61K | 0.19% | 100 |
|
|
2023
Q3 | $1.3M | Buy |
16,646
+555
| +3% | +$46.5K | 0.19% | 101 |
|
|
2023
Q2 | $1.42M | Buy |
16,091
+11,559
| +255% | +$995K | 0.2% | 97 |
|
|
2023
Q1 | $365K | Sell |
4,532
-383
| -8% | -$31.2K | 0.05% | 206 |
|
|
2022
Q4 | $382K | Sell |
4,915
-54,656
| -92% | -$4.43M | 0.06% | 182 |
|
|
2022
Q3 | $4.81M | Sell |
59,571
-22,335
| -27% | -$2.01M | 0.83% | 42 |
|
|
2022
Q2 | $7.35M | Buy |
81,906
+81,139
| +10,579% | +$8.22M | 1.18% | 28 |
|
|
2022
Q1 | $85K | Sell |
767
-1,533
| -67% | -$162K | 0.02% | 158 |
|
|
2021
Q4 | $238K | Buy |
2,300
+109
| +5% | +$12.6K | 0.03% | 208 |
|
|
2021
Q3 | $275K | Sell |
2,191
-586
| -21% | -$75.8K | 0.04% | 195 |
|
|
2021
Q2 | $345K | Buy |
2,777
+381
| +16% | +$47.8K | 0.05% | 195 |
|
|
2021
Q1 | $283K | Sell |
2,396
-360
| -13% | -$42.2K | 0.04% | 202 |
|
|
2020
Q4 | $323K | Sell |
2,756
-1,709
| -38% | -$188K | 0.05% | 180 |
|
|
2020
Q3 | $464K | Buy |
4,465
+1,392
| +45% | +$140K | 0.09% | 130 |
|
|
2020
Q2 | $282K | Buy |
+3,073
| New | +$295K | 0.06% | 143 |
|
|
2017
Q3 | – | Sell |
-35,763
| Closed | -$3.17M | – | 220 |
|
|
2017
Q2 | $3.17M | Buy |
35,763
+1,277
| +4% | +$108K | 0.83% | 49 |
|
|
2017
Q1 | $2.78M | Sell |
34,486
-11,430
| -25% | -$893K | 0.73% | 58 |
|
|
2016
Q4 | $3.27M | Buy |
45,916
+2,774
| +6% | +$218K | 0.92% | 41 |
|
|
2016
Q3 | $3.73M | Sell |
43,142
-667
| -2% | -$58.1K | 1.13% | 28 |
|
|
2016
Q2 | $3.8M | Sell |
43,809
-984
| -2% | -$79.6K | 1.17% | 25 |
|
|
2016
Q1 | $3.36M | Sell |
44,793
-2,310
| -5% | -$174K | 1.06% | 38 |
|
|
2015
Q4 | $3.62M | Sell |
47,103
-341
| -0.7% | -$25.7K | 1.17% | 35 |
|
|
2015
Q3 | $3.18M | Sell |
47,444
-2,025
| -4% | -$149K | 1.13% | 36 |
|
|
2015
Q2 | $3.67M | Buy |
49,469
+12,384
| +33% | +$946K | 1.11% | 41 |
|
|
2015
Q1 | $2.89M | Sell |
37,085
-1,229
| -3% | -$93.1K | 0.83% | 50 |
|
|
2014
Q4 | $2.77M | Buy |
+38,314
| New | +$2.66M | 0.8% | 54 |
|
Other funds holding MDT
VCM
VPM
Greenwood Capital Associates's MDT Position: Q1 2026 in Review
Greenwood Capital Associates reduced its Medtronic (MDT) stake by 22% in Q1 2026, selling an estimated $1.81M and leaving 65,749 shares worth $5.7M. The position accounts for 0.63% of the portfolio, ranked #51.
Greenwood Capital Associates first reported a position in MDT in Q4 2014 and has held it in 35 quarters since. The position peaked at $10M in Q1 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Greenwood Capital Associates held 65,749 shares of Medtronic worth $5.7M as of Q1 2026.
- Greenwood Capital Associates sold 18,868 Medtronic shares in Q1 2026, an estimated $1.81M.
- Medtronic made up 0.63% of Greenwood Capital Associates's portfolio in Q1 2026, its #51 holding.
- Greenwood Capital Associates first reported a position in Medtronic in Q4 2014 and has held it in 35 quarters since.
- Greenwood Capital Associates's Medtronic position peaked at $10M in Q1 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Greenwood Capital Associates's 13F filing for Q1 2026, filed 29 Apr 2026.